Madrigal Pharma
MDGL472.96013.52% ( -73.920 )
Madrigal Pharma (MDGL)
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH...
- Open
- 505.550
- High
- 510.550
- Low
- 447.525
- Prev. Close
- 546.880
- Volume
- 753.83K
- Turnover
- 354.74M
- Avg Price
- 470.587
- Bid/Ask Ratio
- --
- Amplitude
- 11.52%
- 52wk High
- 615.000
- Volume Ratio
- 13.14
- Turnover Ratio
- 5.44%
Madrigal Pharma Analyst Rating
View MoreForecast & Rating
Jul 30, 2026Price forecast
$680.6041.86%
Forecast & RatingStrong buy
17analysts
- Strong buy70.59%
- Buy17.65%
- Hold11.76%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · 2 hours ago
MADRIGAL PHARMACEUTICALS, INC. Q2 2026: Revenue $364.25M, EPS ($1.99) — 10-Q Summary
- TradingView · 3 hours ago
Madrigal reports Q2 2026 Rezdiffra sales $364.3M; net loss $57.9M
- Earnings Watch · 4 hours ago
Madrigal Pharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 364.3 M
- benzinga_article · 1 day ago, 12:35 PM
4 Health Care Stocks With Whale Alerts In Today’s Session
- Market Beat · 2 days ago, 05:30 AM
Madrigal Pharmaceuticals (NASDAQ:MDGL) Raised to "Strong-Buy" at Wells Fargo & Company
- Tip Ranks · Jul 21 at 04:49 PM
Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS
